Glioblastoma Drugs Market Size, Share & Industry Analysis, By Drug (Temozolomide, Bevacizumab, Carmustine, Lomustine, Procarbazine, and Others), By Drug Class (Alkylating Agents, VEGF/Angiogenesis Inhibitors, Nitrosoureas, Platinum Compounds, Topoisomerase Inhibitors, and Others), By Age Group (Pediatric and Adults), By Type (Branded and Generic), By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, and Others), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Others), and Regional Forecast, 2026-2034

Last Updated: April 30, 2026 | Format: PDF | Report ID: FBI116045

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR of 4.82% from 2026 to 2034
Unit	Value (USD Billion)
Segmentation	By Drug, Drug Class, Age Group, Type, Therapy, Route of Administration, Distribution Channel, and Region
By Drug	Temozolomide Bevacizumab Carmustine Lomustine Procarbazine Irinotecan Others
By Drug Class	Alkylating agents VEGF / angiogenesis inhibitors Nitrosoureas Platinum compounds Topoisomerase inhibitors Immune checkpoint inhibitors Others
By Age Group	Pediatric Adults
By Type	Branded Generic
By Therapy	Targeted Therapy Immunotherapy Chemotherapy Others
By Route of Administration	Oral Parenteral
By Distribution Channel	Hospital pharmacies Drug stores & retail pharmacies Online pharmacies
By Region	North America (By Drug, Drug Class, Age Group, Type, Therapy, Route of Administration, Distribution Channel, and Country) U.S. Canada Europe (By Drug, Drug Class, Age Group, Type, Therapy, Route of Administration, Distribution Channel, and Country/Sub-region) Germany U.K. France Spain Italy Scandinavia Rest of Europe Asia Pacific (By Drug, Drug Class, Age Group, Type, Therapy, Route of Administration, Distribution Channel, and Country/Sub-region) China Japan India Australia Southeast Asia Rest of Asia Pacific Latin America (By Drug, Drug Class, Age Group, Type, Therapy, Route of Administration, Distribution Channel, and Country/Sub-region) Brazil Mexico Rest of Latin America Middle East & Africa (By Drug, Drug Class, Age Group, Type, Therapy, Route of Administration, Distribution Channel, and Country/Sub-region) GCC South Africa Rest of the Middle East & Africa